How many FDA warning letters has Jubilant HollisterStier General Partnership received?

Argus HQ has recorded 1 FDA warning letter for Jubilant HollisterStier General Partnership.

What FDA recalls has Jubilant HollisterStier General Partnership issued?

Argus HQ has not recorded an FDA recall tied to Jubilant HollisterStier General Partnership in our current dataset.

Is Jubilant HollisterStier General Partnership FDA compliant?

Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 1 warning letter, 0 recalls, and 0 approval records for Jubilant HollisterStier General Partnership. Review the linked FDA source records directly before drawing a compliance conclusion.

.hq

company

Jubilant HollisterStier General Partnership

Name: FDA Enforcement Actions Against Jubilant HollisterStier General Partnership
Creator: Argus HQ
License: https://argushq.ai/methodology

Industry: pharmaceutical

Jurisdiction: US

FDA Warning Letter timeline

V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.

fda_warning_letter · cgmp2026-05-28
Jubilant HollisterStier General Partnership — CGMP/Finished Pharmaceuticals/Adulterated (2026-05-28)

Frequently asked questions

How many FDA warning letters has Jubilant HollisterStier General Partnership received?: Argus HQ has recorded 1 FDA warning letter for Jubilant HollisterStier General Partnership.
What FDA recalls has Jubilant HollisterStier General Partnership issued?: Argus HQ has not recorded an FDA recall tied to Jubilant HollisterStier General Partnership in our current dataset.
Is Jubilant HollisterStier General Partnership FDA compliant?: Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 1 warning letter, 0 recalls, and 0 approval records for Jubilant HollisterStier General Partnership. Review the linked FDA source records directly before drawing a compliance conclusion.

Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.